BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34964144)

  • 1. Modulation of Notch signaling and angiogenesis via an isolated polysaccharide from Momordica charantia in diabetic rats.
    Sajadimajd S; Mohammadi B; Bahrami G; Madani SH; Hatami R; Miraghaee SS
    J Food Biochem; 2022 Feb; 46(2):e14033. PubMed ID: 34964144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch signaling-induced cyclin d1 in diabetes ameliorating effects of the isolated polysaccharide from Rosa canina: In vitro and in vivo studies.
    Sajadimajd S; Bahrami G; Mohammadi B; Madani SH
    Cell Biochem Funct; 2022 Dec; 40(8):935-945. PubMed ID: 36285737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysaccharide from fermented Momordica charantia L. with Lactobacillus plantarum NCU116 ameliorates type 2 diabetes in rats.
    Gao H; Wen JJ; Hu JL; Nie QX; Chen HH; Xiong T; Nie SP; Xie MY
    Carbohydr Polym; 2018 Dec; 201():624-633. PubMed ID: 30241862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Momordica charantia polysaccharides mitigate the progression of STZ induced diabetic nephropathy in rats.
    Raish M; Ahmad A; Jan BL; Alkharfy KM; Ansari MA; Mohsin K; Jenoobi FA; Al-Mohizea A
    Int J Biol Macromol; 2016 Oct; 91():394-9. PubMed ID: 27238589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-diabetic properties of Momordica charantia L. polysaccharide in alloxan-induced diabetic mice.
    Xu X; Shan B; Liao CH; Xie JH; Wen PW; Shi JY
    Int J Biol Macromol; 2015 Nov; 81():538-43. PubMed ID: 26318666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Momordica charantia L. polysaccharide and its protective effect on pancreatic cells injury in STZ-induced diabetic mice.
    Zhang C; Chen H; Bai W
    Int J Biol Macromol; 2018 Aug; 115():45-52. PubMed ID: 29649536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat.
    Ahmed I; Adeghate E; Cummings E; Sharma AK; Singh J
    Mol Cell Biochem; 2004 Jun; 261(1-2):63-70. PubMed ID: 15362486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Treatment Efficacy of Essential Oil Isolated from Seeds of Momordica charantia in Streptozotocin-Induced Diabetes Mellitus.
    Mariammal BGV; Devarajan DW; Jerrin R; Viswanathan S; Siddikuzzaman ; Gopal R
    Recent Pat Biotechnol; 2021; 15(4):316-331. PubMed ID: 34515016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects and mechanisms of Momordica charantia polysaccharide on early-stage diabetic retinopathy in type 1 diabetes.
    Liu J; Liu Y; Sun J; Guo Y; Lei Y; Guo M; Wang L
    Biomed Pharmacother; 2023 Dec; 168():115726. PubMed ID: 37862973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of pancreatic β-cells in neonatally streptozotocin-induced type 2 diabetic rats by the ethanolic extract of Momordica charantia fruit pulp.
    Hafizur RM; Kabir N; Chishti S
    Nat Prod Res; 2011 Feb; 25(4):353-67. PubMed ID: 21328131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the antidiabetic activities of Momordica charantia fruit juice in streptozotocin-induced diabetic rats.
    Mahmoud MF; El Ashry FE; El Maraghy NN; Fahmy A
    Pharm Biol; 2017 Dec; 55(1):758-765. PubMed ID: 28064559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of a Momordica charantia L. polysaccharide‑chromium (III) complex and its anti-hyperglycemic activity in mice with streptozotocin-induced diabetes.
    Zhang C; Huang M; Hong R; Chen H
    Int J Biol Macromol; 2019 Feb; 122():619-627. PubMed ID: 30391593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Momordica charantia reverses type II diabetes in rat.
    Malekshahi H; Bahrami G; Miraghaee S; Ahmadi SA; Sajadimajd S; Hatami R; Mohammadi B; Keshavarzi S
    J Food Biochem; 2019 Nov; 43(11):e13021. PubMed ID: 31441956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant activity of Momordica charantia polysaccharide and its derivatives.
    Chen F; Huang G; Yang Z; Hou Y
    Int J Biol Macromol; 2019 Oct; 138():673-680. PubMed ID: 31344411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic analysis of Momordica charantia polysaccharide on streptozotocin-induced diabetic rats.
    Bai W; Zhang C; Chen H
    Gene; 2018 Oct; 675():208-216. PubMed ID: 30180967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of selenylated polysaccharides from Momordica charantia L. and its hypoglycemic activity in streptozotocin-induced diabetic mice.
    Ru Y; Liu K; Kong X; Li X; Shi X; Chen H
    Int J Biol Macromol; 2020 Jun; 152():295-304. PubMed ID: 32112833
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Soliman GA; Abdel-Rahman RF; Ogaly HA; Althurwi HN; Abd-Elsalam RM; Albaqami FF; Abdel-Kader MS
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33187275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cucurbitane Triterpenoids from the Fruits of Momordica Charantia Improve Insulin Sensitivity and Glucose Homeostasis in Streptozotocin-Induced Diabetic Mice.
    Han JH; Tuan NQ; Park MH; Quan KT; Oh J; Heo KS; Na M; Myung CS
    Mol Nutr Food Res; 2018 Apr; 62(7):e1700769. PubMed ID: 29405623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice.
    Wang Q; Wu X; Shi F; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():744-750. PubMed ID: 30551527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLP-I secretion in healthy and diabetic Wistar rats in response to aqueous extract of Momordica charantia.
    Bhat GA; Khan HA; Alhomida AS; Sharma P; Singh R; Paray BA
    BMC Complement Altern Med; 2018 May; 18(1):162. PubMed ID: 29776414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.